1.5(top 50%)
impact factor
118(top 100%)
papers
2.3K(top 50%)
citations
26(top 20%)
h-index
1.5(top 50%)
impact factor
121
all documents
2.3K
doc citations
46(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Withdrawal of cerivastatin from the world marketCurrent Controlled Trials in Cardiovascular Medicine2001329
2Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitorsCurrent Controlled Trials in Cardiovascular Medicine2005198
3Problems in dealing with missing data and informative censoring in clinical trialsCurrent Controlled Trials in Cardiovascular Medicine2002134
4Are statins anti-inflammatory?Current Controlled Trials in Cardiovascular Medicine200084
5Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]Current Controlled Trials in Cardiovascular Medicine200582
6Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyCurrent Controlled Trials in Cardiovascular Medicine200178
7The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialCurrent Controlled Trials in Cardiovascular Medicine200173
8Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA studyCurrent Controlled Trials in Cardiovascular Medicine200571
9Systematic adjudication of myocardial infarction end-points in an international clinical trialCurrent Controlled Trials in Cardiovascular Medicine200166
10Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneCurrent Controlled Trials in Cardiovascular Medicine200266
11Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarctionCurrent Controlled Trials in Cardiovascular Medicine200551
12Methodological considerations in the design of trials for safety assessment of new drugs and chemical entitiesCurrent Controlled Trials in Cardiovascular Medicine200540
13Cytokines as new treatment targets in chronic heart failureCurrent Controlled Trials in Cardiovascular Medicine200139
14Pooling, meta-analysis, and the evaluation of drug safetyCurrent Controlled Trials in Cardiovascular Medicine200239
15Therapeutic angiogenesis for cardiovascular diseaseCurrent Controlled Trials in Cardiovascular Medicine200138
16A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsCurrent Controlled Trials in Cardiovascular Medicine200238
17Why do antioxidants fail to provide clinical benefit?Current Controlled Trials in Cardiovascular Medicine200036
18The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]Current Controlled Trials in Cardiovascular Medicine200534
19Long-term outcome after coronary stentingCurrent Controlled Trials in Cardiovascular Medicine200033
20Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: A retrospective analysisCurrent Controlled Trials in Cardiovascular Medicine200332
21Implications of troponin testing in clinical medicineCurrent Controlled Trials in Cardiovascular Medicine200131
22Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in womenCurrent Controlled Trials in Cardiovascular Medicine200131
23The role of dyslipidemia and statins in venous thromboembolismCurrent Controlled Trials in Cardiovascular Medicine200131
24Cardiac rehabilitation: a comprehensive reviewCurrent Controlled Trials in Cardiovascular Medicine200129
25Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement – is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I)Current Controlled Trials in Cardiovascular Medicine200529
26Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic reviewCurrent Controlled Trials in Cardiovascular Medicine200528
27Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulationCurrent Controlled Trials in Cardiovascular Medicine200527
28Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trialCurrent Controlled Trials in Cardiovascular Medicine200026
29Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control studyCurrent Controlled Trials in Cardiovascular Medicine200426
30Importance of the TIMI frame count: implications for future trialsCurrent Controlled Trials in Cardiovascular Medicine200024
31New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy productsCurrent Controlled Trials in Cardiovascular Medicine200124
32Distal protection devices during percutaneous coronary and carotid interventionsCurrent Controlled Trials in Cardiovascular Medicine200123
33The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]Current Controlled Trials in Cardiovascular Medicine200523
34The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?Current Controlled Trials in Cardiovascular Medicine200122
35Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)Current Controlled Trials in Cardiovascular Medicine200422
36A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline dataCurrent Controlled Trials in Cardiovascular Medicine200221
37Antiplatelet and anticoagulant therapy in elective percutaneous coronary interventionCurrent Controlled Trials in Cardiovascular Medicine200120
38Weight-modification trials in older adults: what should the outcome measure be?Current Controlled Trials in Cardiovascular Medicine200220
39Informative noncompliance in endpoint trialsCurrent Controlled Trials in Cardiovascular Medicine200419
40The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)Current Controlled Trials in Cardiovascular Medicine200519
41Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trialCurrent Controlled Trials in Cardiovascular Medicine200017
42A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension TherapyCurrent Controlled Trials in Cardiovascular Medicine200217
43Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]Current Controlled Trials in Cardiovascular Medicine200517
44Compliance of a cobalt chromium coronary stent alloy – the COVIS trialCurrent Controlled Trials in Cardiovascular Medicine200516
45How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)Current Controlled Trials in Cardiovascular Medicine200112
46Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factorsCurrent Controlled Trials in Cardiovascular Medicine200212
47Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study)Current Controlled Trials in Cardiovascular Medicine200011
48A review of clinical trials in dietary interventions to decrease the incidence of coronary artery diseaseCurrent Controlled Trials in Cardiovascular Medicine200111
49A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient managementCurrent Controlled Trials in Cardiovascular Medicine200411
50Medical errors: how the US Government is addressing the problemCurrent Controlled Trials in Cardiovascular Medicine20009